Does APREMILAST Cause Mobility decreased? 2,032 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,032 reports of Mobility decreased have been filed in association with APREMILAST (Otezla). This represents 1.5% of all adverse event reports for APREMILAST.
2,032
Reports of Mobility decreased with APREMILAST
1.5%
of all APREMILAST reports
1,450
Deaths
1,432
Hospitalizations
How Dangerous Is Mobility decreased From APREMILAST?
Of the 2,032 reports, 1,450 (71.4%) resulted in death, 1,432 (70.5%) required hospitalization, and 1,367 (67.3%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APREMILAST. However, 2,032 reports have been filed with the FAERS database.
What Other Side Effects Does APREMILAST Cause?
Diarrhoea (23,752)
Nausea (21,352)
Psoriasis (19,255)
Headache (17,024)
Drug ineffective (14,121)
Abdominal discomfort (7,653)
Psoriatic arthropathy (7,035)
Vomiting (5,959)
Rash (5,883)
Pain (5,676)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which APREMILAST Alternatives Have Lower Mobility decreased Risk?
APREMILAST vs APREPITANT
APREMILAST vs APROTININ
APREMILAST vs ARANESP
APREMILAST vs ARAVA
APREMILAST vs AREDIA